Literature DB >> 4372559

Cell-mediated immunity to Epstein-Barr virus and a blocking factor in patients with infectious mononucleosis.

P K Lai, E M Mackay-Scollay, P J Fimmel, M P Alpers, D Keast.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4372559     DOI： 10.1038/252608a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

1.  Development of cell-mediated immunity to Epstein-Barr herpesvirus in infectious mononucleosis as shown by leukocyte migration inhibition.

Authors:  P K Lai; M P Alpers; E M MacKay-Scollay
Journal:  Infect Immun       Date:  1977-07       Impact factor: 3.441

2.  Blastogenic response of purified human T-lymphocyte populations to Epstein-Barr virus (EBV).

Authors:  P Gergely; I Ernberg; G Klein; M Steinitz
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

3.  Serum modulation of in vitro cellular immune reactivity to Epstein-Barr virus-associated antigen.

Authors:  P G Holt; P J Fimmel; L M Roberts; D Keast
Journal:  Med Microbiol Immunol       Date:  1976-12-01       Impact factor: 3.402

4.  Purified plasminogen activating factor produced by malignant lymphoid cells abrogates lymphocyte cytotoxicity.

Authors:  S K Sundar; J Bergeron; J Menezes
Journal:  Clin Exp Immunol       Date:  1984-06       Impact factor: 4.330

5.  Relationship of in vitro immune responses to Epstein-Barr herpesvirus and severity of infectious mononucleosis.

Authors:  K Goldstein; P K Lai; M Lightfoote; A P Andrese; D Fuccillo; R J Connor; P H Levine
Journal:  Infect Immun       Date:  1980-09       Impact factor: 3.441
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.